Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of ROTAVAC (ORV 116E) Against Severe Rotavirus Gastroenteritis in Infants
NCT01305109Phase 3Unknown
- Sponsor
- Bharat Biotech
- Start
- Mar 2011
- Primary completion
- Dec 2013
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rotavirus vaccine, live, oral, pentavalent in rotavirus gastroenteritis, sponsored by Bharat Biotech. Status: unknown.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT01305109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01305109.